Contact Activation Pathway Function Blocking Antibody AB023

Department
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
Country
United States
Closing Date
Not specified
Estimated Value
Not disclosed

Summary

The Defense Health Agency is seeking supply of AB023, a function-blocking antibody targeting the contact activation pathway, for military medical research or treatment applications in Texas. The requirement falls under NAICS 541714 (research and development in biotechnology) and involves a specialized biologic research reagent. No set-aside or closing date is currently specified.

Full Description

https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=20de49f99a9540a79933d4a7086edabd

Want tenders like this emailed daily?

Get matched government contracts for your industry every morning. Free forever, with plain-English summaries and direct bid links.

Sign Up Free

Who won similar contracts

Recent government contract awards from the same buyer or for similar work. Public records from open.canada.ca, SAM.gov, and USAspending.gov.

A similar contract went to Evoqua Water Technologies LLC for $626,563 in 2026.

DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCYJ065

A similar contract went to INTELLIGENT HEARING SYSTEMS CORP for $44,125 in 2026.

DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY6640

A similar contract went to COMPASS CG LLC for $234,360 in 2026.

DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCYR410

A similar contract went to CULINARY DEPOT INC. for $23,303 in 2026.

DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY7320

Browse all recent awards →

Similar Tenders